Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2003
06/26/2003US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors
06/26/2003US20030119786 Combinations for the treatment of immunoinflammatory disorders
06/26/2003US20030119748 Use for treatment of inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury.
06/26/2003US20030119729 Promoting survival of substantia nigra neuronal cells by contacting with a trophic amount of a ptc therapeutic; mimics hedgehog-mediated patched signal transduction; treating or preventing Parkinson's Disease
06/26/2003US20030119717 Synergistic activation of regulatory elements by rel proteins and a steroid receptor
06/26/2003US20030119715 Prevent retinoid binding; antiaging agents; activation cell differentiation
06/26/2003US20030119111 G-protein coupled receptor, named 2871 receptor
06/26/2003US20030119095 Novel nucleic acid sequences encoding human vesicle transport protein-like and residue rat-like polypeptides
06/26/2003US20030119076 B7-like polynucleotides, polypeptides, and antibodies
06/26/2003US20030118990 Novel estrogen-regulated G protein gamma subunit: compositions and methods of use
06/26/2003US20030118988 Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof
06/26/2003US20030118672 Administering a stabilized rice bran derivative and a fortification agent; treating bone disorders
06/26/2003US20030118671 Pulverizing, extracting twice with boiling water, filtering, combining the extract and then concentrating
06/26/2003US20030118648 Two combined tablet portions, with different releasing rates; drug delivery providing immediate, sustained and prolonged release
06/26/2003US20030118638 Oral pharmaceutical products containing 17 beta-estradiol-3-lower alkanoate, method of administering the same and process of preparation
06/26/2003US20030118633 Treating unstable or overactive urinary bladder by administering an antimuscarinic agent and an estrogen agonist
06/26/2003US20030118594 Stable formulations of mhc-peptide complexes
06/26/2003US20030118575 Administering a pyrazole compound containing urea or thiourea groups, twice daily to a patient in need of treatment of a cytokine mediated disease
06/26/2003US20030118557 Axon repair
06/26/2003US20030118548 Aqueous solution containing glycerin buffer; controlling pH; freeze drying; mutiple sclerosis therapy
06/26/2003US20030118545 Methods and compositions for treating mammalian nerve tissue injuries
06/26/2003US20030118536 Topical compositions and methods for treatment of adverse effects of ionizing radiation
06/26/2003US20030118528 Topical delivery of codrugs
06/26/2003US20030118507 Methods of using 46828, a human acyl-CoA synthetase
06/26/2003CA2510128A1 Composition, synthesis and therapeutic applications of polyamines
06/26/2003CA2473877A1 Substituted beta-aminoalcohols as pharmaceutical preparations
06/26/2003CA2471777A1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
06/26/2003CA2471589A1 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics
06/26/2003CA2471500A1 Substituted 1,5-diaminopentan-3-ol compounds
06/26/2003CA2470723A1 3,4-dihydro-1h-isoquinolin-2-yl-derivatives
06/26/2003CA2470616A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/26/2003CA2470567A1 Methods and compositions for treatment of central nervous system disorders
06/26/2003CA2470311A1 Method of screening compounds
06/26/2003CA2470236A1 Lactams as tachykinin antagonists
06/26/2003CA2470060A1 Improvements in pharmaceutical compositions
06/26/2003CA2470009A1 The total synthesis of merrilactone a
06/26/2003CA2469976A1 Improvements in pharmaceutical compositions
06/26/2003CA2469950A1 Methods for treatment or prophylaxis of aldosterone-mediated pathogenic effectgs in a subject using an epoxy-steroidal aldosterone antagonist
06/26/2003CA2469944A1 Medicaments comprising n, n'-disubstituted piperazine compounds and their use
06/26/2003CA2469940A1 Solid compositions comprising compounds unstable to oxygen and method for stabilizing them
06/26/2003CA2469799A1 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell
06/26/2003CA2469790A1 Method for treating circadian rhythm disruptions
06/26/2003CA2469786A1 5, 6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists
06/26/2003CA2469200A1 Analgesic delivery systems and methods of use
06/26/2003CA2469108A1 A novel polymorph of sertraline hydrochloride and composition containing thereof, novel methods for preparation of sertraline hydrochloride polymorphs and amorphous form
06/26/2003CA2469048A1 Quinolinones as prostaglandin receptor ligands
06/26/2003CA2468978A1 Therapeutic heterocycles
06/26/2003CA2468448A1 Benzodiazepine derivatives, preparation thereof and use thereof
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003CA2467780A1 N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors
06/26/2003CA2465888A1 Topical compositions and methods for treatment of adverse effects of ionizing radiation
06/26/2003CA2446292A1 Nucleic acid-associated proteins
06/25/2003EP1321465A2 A process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride
06/25/2003EP1321151A1 Antiparkinsonism drugs
06/25/2003EP1321148A1 Cyclotetrasaccharide for augmenting "active-oxygen-eliminating-activity"
06/25/2003EP1321143A1 Combination of N-butyldeoxygalactonojirimycin and glycolipid degrading enzyme in therapy
06/25/2003EP1321139A1 2-indanylamino derivatives for the therapy of chronic pain
06/25/2003EP1320710A1 Drying method for selectively removing volatile components from wet coatings
06/25/2003EP1320614A2 Novel proteases
06/25/2003EP1320603A1 Uses of the gjb6 gene for treating certain types of alopecia including the clouston's syndrome, and for screening compounds capable of being efficient in the treatment of alopecia with genetic susceptibility
06/25/2003EP1320600A1 Transporters and ion channels
06/25/2003EP1320584A2 Transferases
06/25/2003EP1320550A2 G-protein coupled receptors
06/25/2003EP1320548A2 Transporters and ion channels
06/25/2003EP1320531A2 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/25/2003EP1320528A2 Substituted phthalides as anti-convulsive drugs
06/25/2003EP1320526A1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
06/25/2003EP1320523A2 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/25/2003EP1320520A1 Sulfonylguanidine
06/25/2003EP1320369A1 A method of analgesia
06/25/2003EP1320367A1 Process for the preparation of dinapsoline
06/25/2003EP1320365A1 Substituted azole derivatives as inhibitors of corticotropin releasing factor
06/25/2003EP1200442B1 2,3-benzodiazepine derivatives
06/25/2003EP1178981B1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
06/25/2003EP1098896B1 5-bicycloindole compounds
06/25/2003EP1000008B1 Novel thyroid receptor ligands and method
06/25/2003EP0946546B1 Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine
06/25/2003EP0777652B1 Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkanol derivatives
06/25/2003EP0641343B1 4-mercaptoacetylamino-[2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors
06/25/2003CN1426423A Humanized antibodies that sequester amyloid beta peptide
06/25/2003CN1426419A Pharmaceutical compositions containing oligosaccharides and preparation thereof
06/25/2003CN1426412A Novel compounds
06/25/2003CN1426411A 3-(diarylmethylene)-8-azabicyclo [3,2,1] octane derivatives
06/25/2003CN1426405A 新型环状酰胺衍生物 Novel cyclic amide derivative
06/25/2003CN1426401A Novel, slow-acting betamimetics, method for their production and their use as medicaments
06/25/2003CN1426397A Aminopyridines and their use as anticonvulsants and sodium channel blockers
06/25/2003CN1426396A Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
06/25/2003CN1426394A Novel compounds
06/25/2003CN1426393A Novel compounds
06/25/2003CN1426392A Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
06/25/2003CN1426303A Thiazole, imidazole and oxazole compounds and treatments of disorder associated with protein aging
06/25/2003CN1426302A Brain, spinal and nerve injure treatment
06/25/2003CN1425437A Medicine for giving-up drug
06/25/2003CN1425434A Naolejing granular preparation
06/25/2003CN1425423A Traditional Chinese medicine for curing vascular dementia and its preparing method
06/25/2003CN1425411A Medicinal pillow for tranquilizing mind and invigorating brain
06/25/2003CN1425406A Quick action headache medicine
06/25/2003CN1425371A Coated Hypericum perforatus extract micro pill preparation and its preparing process
06/25/2003CN1425314A Sobering up tea and its preparing method
06/25/2003CN1112365C Piperidine derivatives and preparing method and use
1 ... 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 ... 1833